#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15058	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2190	684.2	0	.	n	.	0	C451T	SNP	451	451	C	702	702	T	872	T,C	412,408	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15058	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2190	684.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	917	C	853	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15058	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2190	684.2	0	HET	.	.	.	C162T	.	162	162	C	413	413	C	821	C,T	612,165	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27586	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3543	776.4	0	.	n	.	0	T695C	SNP	695	695	T	1061	1061	C	892	C	827	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27586	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3543	776.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2337	2337	C	851	C,T	787,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27586	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3543	776.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2411	2411	A	846	A,G	799,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27586	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3543	776.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2963	2963	C	823	C	773	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27586	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3543	776.4	0	HET	.	.	.	A1638G	.	1638	1638	A	2004	2004	A	891	A,G	453,386	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1994	folP	855	855	100.0	folP.l15.c17.ctg.1	1472	133.6	1	SNP	p	R229S	1	.	.	685	687	AGC	882	884	AGC	197;195;195	A;G;C	187;187;181	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4998	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	145.2	1	SNP	p	S91F	1	.	.	271	273	TTC	563	565	TTC	170;171;170	T;T,C;C	159;158,1;158	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4998	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	145.2	1	SNP	p	G95N	0	.	.	283	285	GGC	575	577	GGC	168;168;169	G;G,A;C	156;159,1;158	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4998	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3429	145.2	1	SNP	p	D95G	1	.	.	283	285	GGC	575	577	GGC	168;168;169	G;G,A;C	156;159,1;158	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1672	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1378	120.7	1	SNP	p	G45D	0	.	.	133	135	GGC	433	435	GGC	193;193;194	G;G;C	184;186;183	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	904	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1098	82.0	0	.	n	.	0	A197.	DEL	197	197	A	692	692	A	221	A	204	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2781	178.0	1	SNP	p	D86N	0	.	.	256	258	GAC	446	448	GAC	213;214;218	G;A;C	196;198;205	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2781	178.0	1	SNP	p	R87I	0	.	.	259	261	CGT	449	451	CGT	217;219;218	C,T;G;T	201,1;203;201	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2781	178.0	1	SNP	p	S87R	1	.	.	259	261	CGT	449	451	CGT	217;219;218	C,T;G;T	201,1;203;201	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2781	178.0	1	SNP	p	R87W	0	.	.	259	261	CGT	449	451	CGT	217;219;218	C,T;G;T	201,1;203;201	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4982	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2781	178.0	1	SNP	p	S88P	0	.	.	262	264	TCC	452	454	TCC	220;218;215	T;C;C	202;203;200	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4438	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2687	164.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1543	1545	GGC	197;196;198	G;G;C	184;181;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1243	1245	GCC	228;229;230	G;C;C	207;211;211	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1246	1248	ATG	230;230;232	A;T;G	211;210;207	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1258	1260	ACC	224;225;224	A;C;C	204;205;205	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1258	1260	ACC	224;225;224	A;C;C	204;205;205	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1759	1761	ACC	237;238;239	A;C;C	220;220;223	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1813	1815	GCG	237;233;233	G;C;G	229;224;224	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1813	1815	GCG	237;233;233	G;C;G	229;224;224	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1936	1938	GGT	202;201;201	G;G;T	190;192;186	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1945	1947	AGC	186;185;182	A;G;C	175;173;168	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4344	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2435	177.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1963	1965	CCG	159;162;160	C,CGG;C,G;G	116,1;116,1;117	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5902	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3054	192.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1535	1537	CCG	227;227;220	C;C,T;G	206;209,1;202	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2280	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1794	126.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	495	495	C	156	C,G	146,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	354	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	714	17.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	397	399	AAT	18;19;20	A;A;T	18;19;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	354	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	714	17.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	400	402	AAT	19;20;20	A;A;T	19;20;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	354	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	714	17.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	424	426	GCA	20;20;20	G;C;A	19;20;20	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	354	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	714	17.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	447	449	GTA	17;17;17	G;T;A	17;17;17	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	354	porB1a	984	331	90.15	porB1a.l15.c30.ctg.2	714	17.9	0	.	p	.	0	N237fs	FSHIFT	709	709	A	456	456	A	16	A	16	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3020	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1481	203.1	1	SNP	p	G120K	1	.	.	358	360	AAG	658	660	AAG	237;234;234	A;A;G	225;222;221	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3020	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1481	203.1	1	SNP	p	A121N	1	.	.	361	363	AAC	661	663	AAC	233;232;232	A;A;C,A	221;220;219,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3020	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1481	203.1	1	SNP	p	N121D	0	.	.	361	363	AAC	661	663	AAC	233;232;232	A;A;C,A	221;220;219,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11092	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	4704	234.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1222	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	977	124.4	1	SNP	p	V57M	1	.	.	169	171	ATG	515	517	ATG	259;259;258	A;T;G	237;235;233	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
